Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-026891
Filing Date
2022-07-27
Accepted
2022-07-27 18:34:56
Documents
1
Period of Report
2022-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5937
  Complete submission text file 0000899243-22-026891.txt   7248
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Issuer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address
Louie Ngar Yee (Reporting) CIK: 0001913264 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41455 | Film No.: 221112256